Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

523 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Impact of the presence and type of cardiovascular disease on the risk of mortality in type 2 diabetic patients: The DIABET-IC trial.
Gimeno Orna JA, Mañas Martínez AB, Rodríguez Padial L, Anguita Sánchez M, Barrios V, Muñiz García J, Pérez Pérez A; DIABET-IC researchers. Gimeno Orna JA, et al. Among authors: barrios v. Endocrinol Diabetes Nutr (Engl Ed). 2024 Aug-Sep;71(7):278-289. doi: 10.1016/j.endien.2024.07.001. Epub 2024 Aug 1. Endocrinol Diabetes Nutr (Engl Ed). 2024. PMID: 39095283
Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry.
Esteve-Pastor MA, Rivera-Caravaca JM, Roldán V, Sanmartin Fernández M, Arribas F, Masjuan J, Barrios V, Cosin-Sales J, Freixa-Pamias R, Recalde E, Pérez-Cabeza AI, Manuel Vázquez Rodríguez J, Ràfols Priu C, Anguita Sánchez M, Lip GYH, Marin F. Esteve-Pastor MA, et al. Among authors: barrios v. Eur Heart J Cardiovasc Pharmacother. 2022 Dec 15;9(1):38-46. doi: 10.1093/ehjcvp/pvac060. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 36318457
Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort-the DIABET-IC study.
Gonzalez-Manzanares R, Anguita-Gámez M, Muñiz J, Barrios V, Gimeno-Orna JA, Pérez A, Rodríguez-Padial L, Anguita M; DIABETIC-IC study Investigators. Gonzalez-Manzanares R, et al. Among authors: barrios v. Cardiovasc Diabetol. 2024 Jul 16;23(1):253. doi: 10.1186/s12933-024-02358-0. Cardiovasc Diabetol. 2024. PMID: 39014420 Free PMC article.
Post-event follow-up costs in patients with atherosclerotic cardiovascular disease in Spain.
Martínez López I, Gómez Cerezo JF, Gámez JM, Egocheaga Cabello I, Castellanos M, Campuzano Ruiz R, Barrios V, Pallarés-Carratalá V, Rodríguez JM, Morant Talamante N, Parrondo J, Mostaza JM. Martínez López I, et al. Among authors: barrios v. Front Cardiovasc Med. 2024 Feb 28;11:1324537. doi: 10.3389/fcvm.2024.1324537. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 38481954 Free PMC article.
Clinical profile and outcomes in very elderly patients with atrial fibrillation anticoagulated with rivaroxaban: data from the EMIR study.
Marín F, Sánchez MA, Lekuona I, Fernández MS, Barrios V, Muñoz CP, Cosín-Sales J, Pérez Cabeza AI, Schilling VR, Priu CR, Orenes-Piñero E, Esteve-Pastor MA. Marín F, et al. Among authors: barrios v. J Geriatr Cardiol. 2024 Jul 28;21(7):723-732. doi: 10.26599/1671-5411.2024.07.003. J Geriatr Cardiol. 2024. PMID: 39183954 Free PMC article.
Chronic thyrotropin-suppressive therapy with levothyroxine and short-term overt hypothyroidism after thyroxine withdrawal are associated with undesirable cardiovascular effects in patients with differentiated thyroid carcinoma.
Botella-Carretero JI, Gómez-Bueno M, Barrios V, Caballero C, García-Robles R, Sancho J, Escobar-Morreale HF. Botella-Carretero JI, et al. Among authors: barrios v. Endocr Relat Cancer. 2004 Jun;11(2):345-56. doi: 10.1677/erc.0.0110345. Endocr Relat Cancer. 2004. PMID: 15163309
523 results